Curative cell and gene therapies and healthcare system disruption
Potentially curative cell and gene therapies represent a key shift in patient care and will have considerable impact across the patient journey, affecting the...
Industries
Life Sciences
We bring clarity to complex challenges.
For more than 25 years, life science companies, law firms, and regulatory agencies around the globe have turned to CRA’s life sciences consultants when they need clarity and solutions to the industry’s most complex issues. Clients value our deep industry knowledge, rigorous analytic techniques, and decades of hands-on experience spanning thousands of successful engagements.
Our Focus Areas
Trending Topics
Insights: COVID-19
CRA’s Life Sciences consultants have authored a variety of articles that can help life sciences companies unlock powerful insights and respond with confidence to business issues they may be facing.
Engagements
- 01Showcasing the value and revenue potential of an asset in developmentA Biotech company sought to quantify the revenue potential and develop a forecast model for their asset, which is currently in early clinical development – the...View engagement
- 02Advised pharmaceutical firm on aggressive growth strategyConvinced the board of a leading pharmaceuticals company that its approach to a material but non-core asset was depleting value; advocated for a “split” of the...View engagement
- 03Migration of intellectual property for life sciences companyWorked with finance and tax team on a cross-border transaction structure to give a growing life sciences company the ability to migrate IP at a later date if a...View engagement
Contact a Life Sciences expert.
See all Life Sciences expertsUpcoming Events
The Leukemia & Lymphoma Society’s 2021 New England Man & Woman of the Year
CRA is proud to support the New England region of the LLS Man & Woman of the year campaign, a philanthropic competition to support blood cancer research. Ned...
HTAi 2021 Annual Meeting Manchester: Innovation Through HTA
Anthony Barron is moderating an “Issue Panel” on Comprehensive Genomic Profiling (CGP). For more information on this event, click here.
Recent Events
The European Commission’s new Pharmaceutical Strategy: Understanding key policy objectives
The European Commission has recently published a comprehensive package of regulatory reforms for the pharmaceutical sector in the European Union (EU), setting...
Health Innovation: No Citizen Left Behind
Tim Wilsdon is the keynote speaker during the session titled “Access & Affordability.” Please find the video recording of Tim’s presentation here beginning at...